Navigation Links
BioNanomatrix Founder and CSO Dr. Han Cao Awarded Chinese Rising Star Entrepreneur Award
Date:10/7/2010

PHILADELPHIA, Oct. 7 /PRNewswire/ -- BioNanomatrix, Inc., which is developing and commercializing breakthrough single-molecule genomic analysis technology, announced today that Founder and Chief Scientific Officer, Han Cao, Ph.D., was awarded the Chinese Rising Star Entrepreneur Award at the China International Economic and Technical Cooperation Forum in Beijing, China on September 27, 2010.  The award is in recognition of Dr. Cao's entrepreneurial spirit and success in the founding of BioNanomatrix and the development of the Company's novel genomic analysis technology.  

Commenting on the milestone, Edward L. Erickson BioNanomatrix's president and chief executive officer, said: "This is a very great honor for Han and for the company he founded, BioNanomatrix.  We believe that the largest country markets for our products are the USA and China, with China rapidly becoming a world leader in genomics and life science research generally.  We look forward to mutually beneficial collaboration with Chinese research institutions and scientists as we commercialize our revolutionary technology."

About BioNanomatrix

BioNanomatrix, Inc., a privately held genomics company, is developing and commercializing game-changing, proprietary technologies for analysis of large biological molecules, such as nucleic acids that are extremely important in life science research, clinical diagnostic applications, and development of new therapeutics.  This technology is designed to reduce dramatically the time and complexity to analyze the genome.  BioNanomatrix's products will provide users with the means to perform single-molecule analyses on minute biological samples that are essentially impossible, impractical or too expensive with current technology.  For more information, visit: www.bionanomatrix.com.

Note: NANOANALYZER is a registered trademark of BioNanomatrix, Inc. The names of other companies, other entities, products and/or services mentioned herein may be the trademarks of their respective owners. Media Contact:  Tiberend Strategic Advisors, Inc. (212) 827-0020 Farrell Denbyfdenby@tiberendstrategicadvisors.com   orAndrew Mielach amielach@tiberendstrategicadvisors.com  
'/>"/>

SOURCE BioNanomatrix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. BioNanomatrix Announces Appointment of Dr. Pui-Yan Kwok to Its Scientific Advisory Board
2. BioNanomatrix Appoints Michael Kochersperger as Vice President of Engineering
3. BioNanomatrixs Revolutionary Whole Genome Analysis Platform Named to MIT Technology Reviews Annual 10 Emerging Technologies List
4. BioNanomatrix Appoints Genomic Research Experts Charles Lee and David L. Barker as Advisers
5. BioNanomatrix Awarded Supplemental Funding to Accelerate Commercialization of Innovative Single-Molecule Analyzer
6. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
7. SENOMYX CO-FOUNDER AND SCIENTIFIC ADVISORY BOARD MEMBER ROGER TSIEN, PH.D., AWARDED NOBEL PRIZE IN CHEMISTRY
8. Boston Scientific Provides Update on Involuntary Selling of Its Stock by Co-Founders
9. Fina Technologies Names Spotfire Founder Christopher Ahlberg to Board of Directors
10. Amylin Co-Founder Announces Plans to Vote for Eastbourne Slate
11. Scripps Research Institute Highlights Groundbreaking Work of aTyr Pharma Scientific Co-Founder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2017)... ... July 24, 2017 , ... Each year, Inavero’s Best of ... their superior service quality as rated by hiring professionals and job candidates. In ... on service quality ratings from their placed talent. , Fewer than 2% of ...
(Date:7/20/2017)... ... 2017 , ... Dr. Asher Kimchi, Founder and Chairman of the International ... at the 22nd World Congress on Heart Disease held in Vancouver, BC, Canada. In ... Distinguished Fellowship Awards. , Dr. Asher Kimchi, together with Co-Chairmen Dr. John A. Elefteriades ...
(Date:7/20/2017)... DENVER and PLYMOUTH, Minn., July 20, 2017 ... LLC , a personalized genetic evaluations company, today ... under their partnership investigating a genetic mutation implicated ... to extend the partnership for a second case ... Last year, the KCNQ2 Cure Alliance and Pairnomix ...
(Date:7/18/2017)... ... ... Sourcing custom glass or quartz parts can be a daunting task. Finding ... your job can take many hours of emails, phone calls and on-line research. Wilmad-LabGlass’ ... the company’s capabilities and core custom categories, and enables you to start the quoting ...
Breaking Biology Technology:
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
(Date:3/30/2017)... 2017 Trends, opportunities and forecast in this ... technology (fingerprint, AFIS, iris recognition, facial recognition, hand geometry, ... end use industry (government and law enforcement, commercial and ... and others), and by region ( North America ... Asia Pacific , and the Rest of the ...
(Date:3/27/2017)... ROCKVILLE CENTRE, N.Y. , March 27, 2017 ... by Healthcare Information and Management Systems Society (HIMSS) ... Analytics Outpatient EMR Adoption Model sm . In ... top 12% of U.S. hospitals using an electronic ... recognized CHS for its high level of EMR ...
Breaking Biology News(10 mins):